SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000950124-01-001239
Filing Date
2001-03-13
Accepted
2001-03-13 00:00:00
Documents
6
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K c60732e10-k405.txt 10-K405 117928
2 1993 STOCK OPTION PLAN c60732ex10-8.txt EX-10.8 38373
3 1993 RESTRICTED STOCK PLAN c60732ex10-9.txt EX-10.9 20994
4 PORTIONS OF THE COMPANY'S ANNUAL REPORT c60732ex13.txt EX-13 98213
5 SUBSIDIARIES OF REGISTRANT c60732ex21.txt EX-21 853
6 CONSENT OF ERNST & YOUNG LLP c60732ex23-1.txt EX-23.1 1448
  Complete submission text file 0000950124-01-001239.txt   280008
Mailing Address 425 WOODSMILL RD ST LOUIS MO 63017
Business Address 425 WOODSMILL RD ST LOUIS MO 63017 3145799899
SHEFFIELD PHARMACEUTICALS INC (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 001-12584 | Film No.: 1566812
SIC: 2834 Pharmaceutical Preparations